![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/spacer.gif)
MART-1 antigen A tumor-associated melanocytic differentiation antigen. Vaccination with MART-1 antigen may stimulate a host cytotoxic T-cell response against tumor cells expressing the melanocytic differentiation antigen, resulting in tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/spacer.gif) | Antigen LB39-AA Antigen SK29-AA MART-1 MART-1 Tumor Antigen Melan A Melan-A Protein Melanoma Antigen Recognized by T-Cells 1 MLANA MLANA Protein | | ![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081025012421im_/http://www.cancer.gov/images/spacer.gif) |